A diagnostic test for preclinical and clinical Alzheimer's disease is based on plasma levels of A beta 40, A beta 42, their ratio, or their rate of entry following administration of antibodies that sequester A beta . Alterations of any of these parameters from control values identifies preclinical or clinical Alzheimer's disease.
申请公布号
WO03015617(A2)
申请公布日期
2003.02.27
申请号
WO2002US26321
申请日期
2002.08.16
申请人
WASHINGTON UNIVERSITY;ELI LILLY AND COMPANY;HOLTZMAN, DAVID, M.;DEMATTOS, RONALD;BALES, KELLY, R.;CUMMINS, DAVID, J.;PAUL, STEVEN, M.
发明人
HOLTZMAN, DAVID, M.;DEMATTOS, RONALD;BALES, KELLY, R.;CUMMINS, DAVID, J.;PAUL, STEVEN, M.
